Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
Clinical trial NCT01131351 · TERMINATED
Trial details
- NCT number
- NCT01131351
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-19
- Primary completion
- 2011-05-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.